PMID: 2499208Jun 1, 1989Paper

The myofibroblast. Possible derivation from macrophages in xanthogranuloma

The American Journal of Dermatopathology
J Bhawan, G Majno

Abstract

The myofibroblast, a cell with features of both fibroblasts and smooth muscle cells, was described originally in granulation tissue. Since then it has been seen in various neoplastic and nonneoplastic conditions. However, there are still unanswered questions regarding the origin of the myofibroblast. Although the cell's derivation from fibroblasts seems clearly established, it has been proposed that these cells arise from the peritoneal macrophages around free-floating intraperitoneal blood clots in rats. We have studied a case of juvenile xanthogranuloma by light and electron microscopy. The histologic features were typical, although the Touton type of giant cells were uncommon. Electron microscopy showed lipid-containing macrophages; many of these also contained the transversely banded bundles of fibrils characteristic of myofibroblasts. These findings support the macrophage origin of myofibroblasts in humans.

Citations

Nov 11, 1992·Journal of the American College of Cardiology·R S SchwartzE J Topol
Jun 6, 2002·Atherosclerosis·Antoni Bayes-GenisRobert S Schwartz
Jan 1, 1993·Journal of Clinical Pathology·M GuarinoE Cristofori
Feb 7, 2007·International Review of Cytology·Ian A Darby, Tim D Hewitson
Jul 1, 1993·Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology·R Vracko, D Thorning
Aug 1, 1995·Journal of Cutaneous Pathology·V G PrietoC R Shea
Aug 10, 2007·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Marilena VeredDan Dayan
May 25, 2006·Experimental Eye Research·William J Dupps, Steven E Wilson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.